Michael Berry

Chief Tech/Sci/R&D Officer bei EVEREST MEDICINES LIMITED

59 Jahre

Health Technology

Consumer Services

Aktive Positionen von Michael Berry

Unternehmen	Position	Beginn	Ende
EVEREST MEDICINES LIMITED	Chief Tech/Sci/R&D Officer	15.06.2023	-

Unternehmen	Position	Beginn	Ende
DYNAVAX TECHNOLOGIES CORPORATION	Corporate Officer/Principal	01.02.2015	01.08.2017
PORTOLA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01.10.2013	01.02.2015
Novartis Vaccines & Diagnostics SL	Corporate Officer/Principal	01.04.2010	01.09.2013
ARCA BIOPHARMA, INC.	Director/Board Member	01.04.2005	01.05.2009
CLOVER BIOPHARMACEUTICALS, LTD.	Chief Tech/Sci/R&D Officer	15.03.2021	-

The University of Manchester	Graduate Degree
University of Manitoba	Doctorate Degree
De Montfort University	Undergraduate Degree

International

Operativ

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	2
Director/Board Member	1

Sektoral

Health Technology	6
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
DYNAVAX TECHNOLOGIES CORPORATION	Health Technology
ARCA BIOPHARMA, INC.	Health Technology
EVEREST MEDICINES LIMITED	Health Technology
CLOVER BIOPHARMACEUTICALS, LTD.	Health Technology

Private Unternehmen	2
Portola Pharmaceuticals LLC Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.	Health Technology
Novartis Vaccines & Diagnostics SL

Private Unternehmen

Health Technology

Novartis Vaccines & Diagnostics SL